Join our Newsletter
Browse by Category
-
Most Read This Week
- SARS-like coronavirus possibly found in New York
- Vical Incorporated announces results of herpes vaccine trial
- Vaccines could save more than 23 million lives by 2020
- NIH studying newly emerging Staphylococcus aureus strain
- Study: Whole-cell vaccines more effective for pertussis than acellular
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: Staphylococcus aureus
Staph infection vaccine trial cut short
Tweet A promising vaccine meant to protect heart surgery patients from staph infections was recently found to be no better than a placebo. The vaccine – V710 – was studied in approximately 8,000 patients in 26 countries as part of … Read More »
NIH studying newly emerging Staphylococcus aureus strain
Tweet A team of National Institute of Health scientists and their colleagues are using household surveillance and genome sequencing to investigate a newly emerging type of Staphylococcus aureus bacteria. The methicillin-resistant bacteria, which is known as livestock-associated ST398, has caused … Read More »
Ohio sees new strain of MRSA
Health officials in Ohio say they have encountered a particularly stubborn strain of methicillin-resistant Staphylococcus aureus, or MRSA, which is a common bacterial infection that is usually acquired in hospitals. Read More »
New methods of preventing MRSA revealed
Two studies have emerged that suggest there may be ways to prevent infections caused by the drug resistant bacteria Staphylococcus aureus, also known as MRSA. Read More »
Inhibitex says recruitment begins for staph vaccine study
Pfizer Inc. has initiated patient recruitment for 408-patient, randomized, double-blind Phase I clinical trial to evaluate three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine in healthy adults. Read More »